作者: 貞潔 時(shí)間: 2025-3-21 22:30 作者: Melanoma 時(shí)間: 2025-3-22 01:31 作者: 單調(diào)女 時(shí)間: 2025-3-22 07:19
Abhishek Subramanian,Ram Rup Sarkar frontline treatment of advanced epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer in combination with carboplatin and paclitaxel, and for the treatment of first recurrence of platinum-sensitive ovarian cancer in combination with carboplatin and gemcitabine. The addition作者: Retrieval 時(shí)間: 2025-3-22 12:48
Do I Understand What I Can Create?,ction and diagnosis of these gynecological tumors is nowadays a primary goal in oncology research. Genomics and proteomics advances and new discoveries about tumor behavior and its specific characteristics bring the attention on several emerging factors that in the next future could become specific 作者: 逃避系列單詞 時(shí)間: 2025-3-22 14:18 作者: 逃避系列單詞 時(shí)間: 2025-3-22 17:48
https://doi.org/10.1007/978-3-030-89680-5isk of infertility and many of these young female cancer patients did not complete their family planning yet at the time of cancer diagnosis, fertility preservation has an emerging importance. Oncofertility is a rising concept requiring the contributions of both gynecologic oncology and reproductive作者: HALO 時(shí)間: 2025-3-22 23:25
Service Providers: Form Over Content,necologic cancer screening and therapy, most often affecting black and Hispanic women. The causes of health disparities are multifactorial and involve systemic, provider, and patient factors, including cultural attitudes, socioeconomic status, education level, and geographic barriers. This chapter d作者: 思考才皺眉 時(shí)間: 2025-3-23 02:48
Epigenetic Mechanisms in Gynecological Cancerc silencing of tumor suppressor genes, mainly due to DNA methylation, representing a relevant mechanism able of modifying the expression of key genes during carcinogenesis. In addition, epigenetic regulation has included microRNAs that regulate gene expression leading to inhibition and/or degradatio作者: absorbed 時(shí)間: 2025-3-23 06:09 作者: 鈍劍 時(shí)間: 2025-3-23 10:49
Advances in Cervical Cancer and Ongoing Clinical Trialsdge acquired in the direction of new and hopefully efficient therapies. In recent years, numerous studies have greatly implemented the knowledge about cervical cancer. It is well known that human papillomavirus (HPV) types cause approximately 90?% of cervical cancer. This evidence led the scientists作者: 正常 時(shí)間: 2025-3-23 14:11
Advances in Ovarian Cancer and Ongoing Clinical Trials frontline treatment of advanced epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer in combination with carboplatin and paclitaxel, and for the treatment of first recurrence of platinum-sensitive ovarian cancer in combination with carboplatin and gemcitabine. The addition作者: 爵士樂(lè) 時(shí)間: 2025-3-23 22:01
Novel Methods for Prevention and Early Diagnosis of Ovarian and Endometrial Cancersction and diagnosis of these gynecological tumors is nowadays a primary goal in oncology research. Genomics and proteomics advances and new discoveries about tumor behavior and its specific characteristics bring the attention on several emerging factors that in the next future could become specific 作者: Capitulate 時(shí)間: 2025-3-24 00:11 作者: exhibit 時(shí)間: 2025-3-24 04:31
Preservation of Fertility in Gynecological Malignanciesisk of infertility and many of these young female cancer patients did not complete their family planning yet at the time of cancer diagnosis, fertility preservation has an emerging importance. Oncofertility is a rising concept requiring the contributions of both gynecologic oncology and reproductive作者: geometrician 時(shí)間: 2025-3-24 09:58
Racial/Ethnic Disparities in Gynecological Cancer Screening, Treatment, and Survivalnecologic cancer screening and therapy, most often affecting black and Hispanic women. The causes of health disparities are multifactorial and involve systemic, provider, and patient factors, including cultural attitudes, socioeconomic status, education level, and geographic barriers. This chapter d作者: 結(jié)合 時(shí)間: 2025-3-24 10:57 作者: FEAS 時(shí)間: 2025-3-24 17:11 作者: 綁架 時(shí)間: 2025-3-24 21:59 作者: 畏縮 時(shí)間: 2025-3-24 23:10 作者: 有特色 時(shí)間: 2025-3-25 06:40 作者: 遺產(chǎn) 時(shí)間: 2025-3-25 08:52 作者: 貨物 時(shí)間: 2025-3-25 12:27 作者: Invertebrate 時(shí)間: 2025-3-25 17:42
Preservation of Fertility in Gynecological Malignanciesanti-estrogen therapy, or any combination of these. Although these therapies can significantly reduce mortality, it can cause long-term toxicity, such as induction of an early menopause and fertility impairment even when the ovaries and the uterus left in place. At the present time, there are severa作者: 被告 時(shí)間: 2025-3-25 21:35 作者: Ordnance 時(shí)間: 2025-3-26 00:32 作者: 同謀 時(shí)間: 2025-3-26 04:19 作者: jocular 時(shí)間: 2025-3-26 08:31 作者: 占卜者 時(shí)間: 2025-3-26 13:10 作者: deficiency 時(shí)間: 2025-3-26 18:00
iGEM: The Competition on Synthetic Biology,bolism are under active investigation in gynecologic malignancies. Immune therapies involving vaccination and adoptive T-cell infusion are also under evaluation to augment innate tumor-specific immunity.作者: 小卷發(fā) 時(shí)間: 2025-3-26 23:03 作者: Gossamer 時(shí)間: 2025-3-27 02:10 作者: 暫停,間歇 時(shí)間: 2025-3-27 07:12
Racial/Ethnic Disparities in Gynecological Cancer Screening, Treatment, and Survivalocuments the disparities in gynecologic cancer screening, treatment, and survival for women with cancers of the cervix, uterus, ovaries, vagina, and vulva. Each disease site has specific areas where minimizing differences in access to care can potentially minimize the disparate health outcomes seen among specific racial and ethnic groups.作者: 黃油沒(méi)有 時(shí)間: 2025-3-27 10:31
Functions, One-to-One, and Onto,ienced high net undercount rates in the Census. While the net undercount rates of Blacks have decreased over time, the differential net undercount between Blacks and Non-Blacks has improved little since 1940.作者: CLAP 時(shí)間: 2025-3-27 15:14
Führung von altersgemischten Arbeitsgruppeniewstudien gut beschreibbaren Probleme und Chancen altersgemischter Teamarbeit werden in konkreten Handlungsempfehlungen gebündelt. Zudem werden zwei Instrumente genauer vorgestellt: Der Fragebogen FAF-16 als Diagnosetool für die Qualit?t alter(n)sgerechter Führung und ein Training zur Führung von altersgemischten Teams.作者: 移動(dòng) 時(shí)間: 2025-3-27 18:11 作者: 聚集 時(shí)間: 2025-3-27 21:57
n when an unbounded polygonal complexity is allowed; however, eight sides are sufficient for Hamiltonian plane graphs. This line of research regarding monotone staircase modules is also motivated by the so-called monotone staircase cuts in VLSI floorplanning. We feel that our results provide a new i作者: HPA533 時(shí)間: 2025-3-28 05:17 作者: surmount 時(shí)間: 2025-3-28 08:24 作者: 出價(jià) 時(shí)間: 2025-3-28 11:26
Die Bewertung der Pfahlform vom Standpunkte der Praxis und der Wirtschaftlichkeit, Natur, sondern auch die Rücksichtnahme auf den Zweck des Bauwerks bei der Erledigung dieser Frage mitbestimmend sein werden. Im folgenden wird versucht, auch unter diesem Gesichtswinkel, soweit eben eine allgemeine Er?rterung m?glich ist, die Frage nach der günstigsten Pfahlform zu behandeln.作者: 擺動(dòng) 時(shí)間: 2025-3-28 16:49
Sociology, Organic Farming, Climate Change and Soil Science978-90-481-3333-8Series ISSN 2210-4410 Series E-ISSN 2210-4429 作者: 飛鏢 時(shí)間: 2025-3-28 21:45
Nutraceuticals Active on Central Nervous System, active dosages, and safety information about Bacoba, Cacao, Chamomille, Curcumin, Escholtzia, Griffonia, Hawthorn, Magnolia, St. John’s wort, Hop, Lavender, Phellodendron, L-arginine and L-lysine, L-theanine, L-tryptophan, Magnesium, Melatonin, Melissa and Passionflower, Ω-3 Polyunsaturated Fatty A
